Synnovation Therapeutics, Inc.

Biotechnology company · Wilmington, Delaware, United States

Synnovation Therapeutics, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Synnovation Therapeutics at a glance

Typebiotechnology company

HeadquartersWilmington, Delaware, United States

Earliest incorporation on record2021

SEC CIK1889137

What does Synnovation Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $15 million sold (2023).

Frequently asked questions about Synnovation Therapeutics

Where is Synnovation Therapeutics headquartered?

Synnovation Therapeutics, Inc. is headquartered in Wilmington, Delaware, United States.

What does Synnovation Therapeutics do?

Synnovation Therapeutics, Inc. is a biotechnology company.

When was Synnovation Therapeutics founded?

The earliest incorporation on record for Synnovation Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
OpiAID, LLCWilmington, North Carolina, United States
Treadwell CorporationWilmington, North Carolina, United States
NiKang Therapeutics, Inc.Wilmington, Delaware, United States
GPN Vaccines, Inc.Wilmington, Delaware, United States
Advanced Materials Technology, Inc.Wilmington, Delaware, United States
Compact Membrane Systems, Inc.Wilmington, Delaware, United States
StimuSIL, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences